Colo. Pharma Co. Faces Securities Suit Over Drug Claims

By Daniel Ducassi · August 19, 2022, 7:16 PM EDT

Colorado pharmaceutical company Ampio is facing a proposed shareholder class action accusing the firm's executives of making false and misleading claims about the efficacy of its star drug, Ampion, which it...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Wang et al v. Ampio Pharmaceuticals, Inc. et al

Case Number

1:22-cv-02105

Court

Colorado

Nature of Suit

Securities, Commodities, Exchange

Date Filed

August 17, 2022